Abstract
Despite recent advances in scientific knowledge and several clinical trials, muscle gene and cell therapies remain a major challenge. As a matter of fact, novel technologies are being developed for targeting muscle tissues including CRISPR, TALEN, and iPS technologies indicating that gene-based therapies still hold significant promises. Recent findings from our laboratory and others unveiled that microRNAs (miRs), small nonprotein-coding RNAs, are able to posttranscriptionally regulate many genes and exert pleiotropic effects in the muscle. Deleterious changes in miR expression play an important role in muscle diseases. In this regard, miRs are possible therapeutic targets, and miR-based gene therapy for smooth, skeletal, and cardiac muscles is an extremely interesting field for harnessing the complexity of miR-based therapeutic approaches. In this chapter, we will focus on miR-driven regulation of myogenic routes in homeostatic and challenging states. We will also survey the intriguing perspective of miR biological transfers, including the delivery of functional miRs via exosomes that unlike other vectors are cell-free natural systems for ferrying RNAs between cells. Finally, we will review the recent literature on key miR targets to treat skeletal, cardiac, and smooth muscle diseases and novel valuable clinical tools for more effective treatment strategies in muscle degeneration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heinrich EM, Dimmeler S (2012) MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circ Res 110(7):1014–1022. https://doi.org/10.1161/circresaha.111.243394
Sharma M, Juvvuna PK, Kukreti H, McFarlane C (2014) Mega roles of microRNAs in regulation of skeletal muscle health and disease. Front Physiol 5:239. https://doi.org/10.3389/fphys.2014.00239
Berardi E, Pues M, Thorrez L, Sampaolesi M (2012) miRNAs in ESC differentiation. Am J Phys Heart Circ Phys 303(8):H931–H939. https://doi.org/10.1152/ajpheart.00338.2012
Quattrocelli M, Sampaolesi M (2015) The mesmiRizing complexity of microRNAs for striated muscle tissue engineering. Adv Drug Deliv Rev 88:37–52. https://doi.org/10.1016/j.addr.2015.04.011
Michell DL, Vickers KC (2016) HDL and microRNA therapeutics in cardiovascular disease. Pharmacol Ther 168:43–52. https://doi.org/10.1016/j.pharmthera.2016.09.001
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. https://doi.org/10.1038/ncb1596
Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3(11):e3694. https://doi.org/10.1371/journal.pone.0003694
Yang N (2015) An overview of viral and nonviral delivery systems for microRNA. Int J Pharm Investig 5(4):179–181. https://doi.org/10.4103/2230-973x.167646
Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27. https://doi.org/10.4103/2277-9175.98152
Ye D, Wang G, Liu Y, Huang W, Wu M, Zhu S, Jia W, Deng AM, Liu H, Kang J (2012) MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling. Stem Cells 30(8):1645–1654. https://doi.org/10.1002/stem.1149
Lee SK, Teng Y, Wong HK, Ng TK, Huang L, Lei P, Choy KW, Liu Y, Zhang M, Lam DS, Yam GH, Pang CP (2011) MicroRNA-145 regulates human corneal epithelial differentiation. PLoS One 6(6):e21249. https://doi.org/10.1371/journal.pone.0021249
Schultz BR, Chamberlain JS (2008) Recombinant adeno-associated virus transduction and integration. Mol Ther 16(7):1189–1199. https://doi.org/10.1038/mt.2008.103
Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M (2012) Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492(7429):376–381
Yang N (2012) Nonviral gene delivery system. Int J Pharm Investig 2(3):97–98. https://doi.org/10.4103/2230-973x.104388
Mathiyalagan P, Sahoo S (2017) Exosomes-based gene therapy for MicroRNA delivery. Methods Mol Biol 1521:139–152. https://doi.org/10.1007/978-1-4939-6588-5_9
Peng B, Chen Y, Leong KW (2015) MicroRNA delivery for regenerative medicine. Adv Drug Deliv Rev 88:108–122. https://doi.org/10.1016/j.addr.2015.05.014
Davidson BL, McCray PB Jr (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12(5):329–340. https://doi.org/10.1038/nrg2968
Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38(2):228–233. https://doi.org/10.1038/ng1725
McCarthy JJ (2008) MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 1779(11):682–691. https://doi.org/10.1016/j.bbagrm.2008.03.001
Dey BK, Gagan J, Dutta A (2011) miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 31(1):203–214. https://doi.org/10.1128/mcb.01009-10
Wong CF, Tellam RL (2008) MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283(15):9836–9843. https://doi.org/10.1074/jbc.M709614200
Crist CG, Montarras D, Pallafacchina G, Rocancourt D, Cumano A, Conway SJ, Buckingham M (2009) Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A 106(32):13383–13387. https://doi.org/10.1073/pnas.0900210106
Feng Y, Cao JH, Li XY, Zhao SH (2011) Inhibition of miR-214 expression represses proliferation and differentiation of C2C12 myoblasts. Cell Biochem Funct 29(5):378–383. https://doi.org/10.1002/cbf.1760
Liu J, Luo XJ, Xiong AW, Zhang ZD, Yue S, Zhu MS, Cheng SY (2010) MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras. J Biol Chem 285(34):26599–26607. https://doi.org/10.1074/jbc.M110.115824
Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A (2006) The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 8(3):278–284. https://doi.org/10.1038/ncb1373
Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 122(6):2054–2065. https://doi.org/10.1172/jci62656
Alexander MS, Casar JC, Motohashi N, Vieira NM, Eisenberg I, Marshall JL, Gasperini MJ, Lek A, Myers JA, Estrella EA, Kang PB, Shapiro F, Rahimov F, Kawahara G, Widrick JJ, Kunkel LM (2014) MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms. J Clin Invest 124(6):2651–2667. https://doi.org/10.1172/jci73579
Ardite E, Perdiguero E, Vidal B, Gutarra S, Serrano AL, Munoz-Canoves P (2012) PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol 196(1):163–175. https://doi.org/10.1083/jcb.201105013
Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93(1):23–67. https://doi.org/10.1152/physrev.00043.2011
Crist CG, Montarras D, Buckingham M (2012) Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell 11(1):118–126. https://doi.org/10.1016/j.stem.2012.03.011
McFarlane C, Vajjala A, Arigela H, Lokireddy S, Ge X, Bonala S, Manickam R, Kambadur R, Sharma M (2014) Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27. PLoS One 9(1):e87687. https://doi.org/10.1371/journal.pone.0087687
Tan SB, Li J, Chen X, Zhang W, Zhang D, Zhang C, Li D, Zhang Y (2014) Small molecule inhibitor of myogenic microRNAs leads to a discovery of miR-221/222-myoD-myomiRs regulatory pathway. Chem Biol 21(10):1265–1270. https://doi.org/10.1016/j.chembiol.2014.06.011
McKinsey TA, Zhang CL, Lu J, Olson EN (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408(6808):106–111. https://doi.org/10.1038/35040593
Lu J, McKinsey TA, Zhang CL, Olson EN (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6(2):233–244
Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang DZ (2010) microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190(5):867–879. https://doi.org/10.1083/jcb.200911036
Anderson C, Catoe H, Werner R (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34(20):5863–5871. https://doi.org/10.1093/nar/gkl743
Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, Zhao SH (2013) A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis 4:e934. https://doi.org/10.1038/cddis.2013.462
Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandona M, Ryan T, Rojas-Munoz A, Madaro L, Fasanaro P, Borsellino G, De Bardi M, Frige G, Termanini A, Sun X, Rossant J, Bruneau BG, Mercola M, Minucci S, Puri PL (2014) HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 28(8):841–857. https://doi.org/10.1101/gad.234468.113
Giordani L, Sandona M, Rotini A, Puri PL, Consalvi S, Saccone V (2014) Muscle-specific microRNAs as biomarkers of Duchenne muscular dystrophy progression and response to therapies. Rare Dis 2(1):e974969. https://doi.org/10.4161/21675511.2014.974969
Basu U, Lozynska O, Moorwood C, Patel G, Wilton SD, Khurana TS (2011) Translational regulation of utrophin by miRNAs. PLoS One 6(12):e29376. https://doi.org/10.1371/journal.pone.0029376
Moorwood C, Soni N, Patel G, Wilton SD, Khurana TS (2013) A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation. J Biomol Screen 18(4):400–406. https://doi.org/10.1177/1087057112465648
Amirouche A, Tadesse H, Miura P, Belanger G, Lunde JA, Cote J, Jasmin BJ (2014) Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle. Nucleic Acids Res 42(6):3982–3997. https://doi.org/10.1093/nar/gkt1350
McCarthy JJ, Esser KA, Andrade FH (2007) MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am J Physiol Cell Physiol 293(1):C451–C457. https://doi.org/10.1152/ajpcell.00077.2007
Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M (2010) Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med 14(10):2495–2505. https://doi.org/10.1111/j.1582-4934.2009.00898.x
Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14(5):369–381. https://doi.org/10.1016/j.ccr.2008.10.006
Zhou L, Wang L, Lu L, Jiang P, Sun H, Wang H (2012) A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis. J Biol Chem 287(30):25255–25265. https://doi.org/10.1074/jbc.M112.357053
Salmons S, Vrbova G (1969) The influence of activity on some contractile characteristics of mammalian fast and slow muscles. J Physiol 201(3):535–549
Webster C, Silberstein L, Hays AP, Blau HM (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52(4):503–513
Selsby JT, Morine KJ, Pendrak K, Barton ER, Sweeney HL (2012) Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PLoS One 7(1):e30063. https://doi.org/10.1371/journal.pone.0030063
von Maltzahn J, Renaud JM, Parise G, Rudnicki MA (2012) Wnt7a treatment ameliorates muscular dystrophy. Proc Natl Acad Sci U S A 109(50):20614–20619. https://doi.org/10.1073/pnas.1215765109
Stupka N, Plant DR, Schertzer JD, Emerson TM, Bassel-Duby R, Olson EN, Lynch GS (2006) Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice. J Physiol 575(Pt 2):645–656. https://doi.org/10.1113/jphysiol.2006.108472
van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17(5):662–673. https://doi.org/10.1016/j.devcel.2009.10.013
Zhang CL, McKinsey TA, Olson EN (2002) Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 22(20):7302–7312
Klingler W, Jurkat-Rott K, Lehmann-Horn F, Schleip R (2012) The role of fibrosis. Acta Myol 31(3):184–195
Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, Nicoletti C, Santini T, Sthandier O, Barberi L, Auricchio A, Musaro A, Bozzoni I (2010) MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 12(4):341–351. https://doi.org/10.1016/j.cmet.2010.07.008
Nguyen-Tran DH, Hait NC, Sperber H, Qi J, Fischer K, Ieronimakis N, Pantoja M, Hays A, Allegood J, Reyes M, Spiegel S, Ruohola-Baker H (2014) Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. Dis Model Mech 7(1):41–54. https://doi.org/10.1242/dmm.013631
Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge DC, Sun H, Wang H (2012) Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 20(6):1222–1233. https://doi.org/10.1038/mt.2012.35
Meadows E, Kota J, Malik V, Clark R, Sahenk Z, Harper S, Mendell J (2014) MicroRNA-29 overexpression delivered by adeno-associated virus suppresses fibrosis in mdx: utrn+/-mice (S61. 003). Neurology 82(10 Supplement):S61-003
Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, Santini T, Sthandier O, Bozzoni I (2011) miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep 12(2):136–141. https://doi.org/10.1038/embor.2010.208
Rodriguez MC, Tarnopolsky MA (2003) Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 34(9):1217–1220
Ragusa RJ, Chow CK, Porter JD (1997) Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord 7(6-7):379–386
Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J (2015) The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes. J Muscle Res Cell Motil 36:377–393. https://doi.org/10.1007/s10974-015-9438-9
Lawler JM (2011) Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy. J Physiol 589(Pt 9):2161–2170. https://doi.org/10.1113/jphysiol.2011.207456
Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS (2014) Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Exp Physiol 99(4):675–687. https://doi.org/10.1113/expphysiol.2013.077255
Rando TA, Disatnik MH, Yu Y, Franco A (1998) Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 8(1):14–21
Matsumura CY, Menezes de Oliveira B, Durbeej M, Marques MJ (2013) Isobaric tagging-based quantification for proteomic analysis: a comparative study of spared and affected muscles from mdx mice at the early phase of dystrophy. PLoS One 8(6):e65831. https://doi.org/10.1371/journal.pone.0065831
Li X, Li Y, Zhao L, Zhang D, Yao X, Zhang H, Wang YC, Wang XY, Xia H, Yan J, Ying H (2014) Circulating muscle-specific miRNAs in Duchenne muscular dystrophy patients. Mol Ther Nucleic Acids 3:e177. https://doi.org/10.1038/mtna.2014.29
Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, Flanigan KM, Neely LA, Whitney D, Beggs AH, Kohane IS, Kunkel LM (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 104(43):17016–17021. https://doi.org/10.1073/pnas.0708115104
Seok HY, Tatsuguchi M, Callis TE, He A, Pu WT, Wang DZ (2011) miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation. J Biol Chem 286(41):35339–35346. https://doi.org/10.1074/jbc.M111.273276
Cruz-Guzmán Odel R, Rodríguez-Cruz M, Escobar Cedillo RE (2015) Systemic inflammation in Duchenne muscular dystrophy: association with muscle function and nutritional status. Biomed Res Int 2015:7. https://doi.org/10.1155/2015/891972
Nie M, Liu J, Yang Q, Seok HY, Hu X, Deng ZL, Wang DZ (2016) MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro- and anti-inflammatory macrophages. Cell Death Dis 7(6):e2261. https://doi.org/10.1038/cddis.2016.165
Ennen JP, Verma M, Asakura A (2013) Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle 3(1):9. https://doi.org/10.1186/2044-5040-3-9
Wang S, Olson EN (2009) AngiomiRs—key regulators of angiogenesis. Curr Opin Genet Dev 19(3):205–211. https://doi.org/10.1016/j.gde.2009.04.002
Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436(7048):214–220
Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22(23):3242–3254. https://doi.org/10.1101/gad.1738708
Ivey KN, Muth A, Arnold J, King FW, Yeh R-F, Fish JE, Hsiao EC, Schwartz RJ, Conklin BR, Bernstein HS (2008) MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2(3):219–229. https://doi.org/10.1016/j.stem.2008.01.016
Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci 103(48):18255–18260
Callis TE, Pandya K, Seok HY, Tang R-H, Tatsuguchi M, Huang Z-P, Chen J-F, Deng Z, Gunn B, Shumate J (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119(9):2772–2786
Hydbring P, Badalian-Very G (2013) Clinical applications of microRNAs. F1000Research 2:136. https://doi.org/10.12688/f1000research.2-136.v3
Chiavacci E, Dolfi L, Verduci L, Meghini F, Gestri G, Evangelista AMM, Wilson SW, Cremisi F, Pitto L (2012) MicroRNA 218 mediates the effects of Tbx5a over-expression on zebrafish heart development. PLoS One 7(11):e50536
Miyasaka KY, Kida YS, Banjo T, Ueki Y, Nagayama K, Matsumoto T, Sato M, Ogura T (2011) Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143. Mech Dev 128(1):18–28
Katz MG, Fargnoli AS, Kendle AP, Hajjar RJ, Bridges CR (2016) The role of microRNAs in cardiac development and regenerative capacity. Am J Phys Heart Circ Phys 310(5):H528–H541
Ogórek B, Hosoda T, Rondon C, Gurusamy N, Gatti A, Bardelli S, Quaini F, Bussani R, Silvestri F, Cesselli D (2010) Myocyte turnover in the aging human heart. Circulation 122(Suppl 21):A17367–A17367
Nadal-Ginard B, Kajstura J, Leri A, Anversa P (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92(2):139–150
Li F, Wang X, Capasso JM, Gerdes AM (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28(8):1737–1746
Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam Y-J, Matkovich SJ, Dorn GW, Van Rooij E, Olson EN (2011) miR-15 family regulates postnatal mitotic arrest of cardiomyocytes novelty and significance. Circ Res 109(6):670–679
Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, Bonauer A (2013) MicroRNA-34a regulates cardiac ageing and function. Nature 495(7439):107–110
Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA (2011) Transient regenerative potential of the neonatal mouse heart. Science 331(6020):1078–1080
Duelen R, Sampaolesi M (2017) Stem cell technology in cardiac regeneration: a pluripotent stem cell promise. EBioMedicine 16:30–40. https://doi.org/10.1016/j.ebiom.2017.01.029
Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124(14):1537–1547. https://doi.org/10.1161/circulationaha.111.030932
Han Y-C, Park CY, Bhagat G, Zhang J, Wang Y, Fan J-B, Liu M, Zou Y, Weissman IL, Gu H (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207:475
Wei W, He H, Zhang W, Zhang H, Bai J, Liu H, Cao J, Chang K, Li X, Zhao S (2013) miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 4(6):e668
da Costa Martins PA, Salic K, Gladka MM, Armand A-S, Leptidis S, El Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, Van Der Nagel R (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12(12):1220–1227
Bernardo BC, Nguyen SS, Winbanks CE, Gao X-M, Boey EJ, Tham YK, Kiriazis H, Ooi JY, Porrello ER, Igoor S (2014) Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. FASEB J 28(12):5097–5110
Huang J, Sun W, Huang H, Ye J, Pan W, Zhong Y, Cheng C, You X, Liu B, Xiong L (2014) miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS One 9(4):e94382
Higashi K, Yamada Y, Minatoguchi S, Baba S, Iwasa M, Kanamori H, Kawasaki M, Nishigaki K, Takemura G, Kumazaki M (2015) MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am J Phys Heart Circ Phys 309(11):H1813–H1826
Su M, Wang J, Wang C, Wang X, Dong W, Qiu W, Wang Y, Zhao X, Zou Y, Song L (2015) MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ 22(6):986–999
Gupta SK, Foinquinos A, Thum S, Remke J, Zimmer K, Bauters C, de Groote P, Boon RA, de Windt LJ, Preissl S (2016) Preclinical development of a microRNA-based therapy for elderly patients with myocardial infarction. J Am Coll Cardiol 68(14):1557–1571
Chen J, Huang Z-P, Seok H, Ding J, Kataoka M, Zhang Z, Hu X, Wang G, Lin Z, Wang S (2013) mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 112(12):1557
Shen Y, Shen Z, Miao L, Xin X, Lin S, Zhu Y, Guo W, Zhu YZ (2015) miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression. Antioxid Redox Signal 22(3):224–240
Crippa S, Cassano M, Messina G, Galli D, Galvez BG, Curk T, Altomare C, Ronzoni F, Toelen J, Gijsbers R (2011) miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol 193(7):1197–1212. https://doi.org/10.1083/jcb.201011099
Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, Morgan J, Calligaro A, Casasco A, Orlacchio A (2013) Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc 2(4):e000284
Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22(10):1282–1289
Schwach V, Passier R (2016) Generation and purification of human stem cell-derived cardiomyocytes. Differentiation 91(4):126–138
Chong JJ, Yang X, Don CW, Minami E, Liu Y-W, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510(7504):273–277. https://doi.org/10.1038/nature13233
Quattrocelli M, Swinnen M, Giacomazzi G, Camps J, Barthélemy I, Ceccarelli G, Caluwé E, Grosemans H, Thorrez L, Pelizzo G, Muijtjens M, Verfaillie CM, Blot S, Janssens S, Sampaolesi M (2015) Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. J Clin Invest 125(12):4463–4482. https://doi.org/10.1172/JCI82735
Mauritz C, Martens A, Rojas SV, Schnick T, Rathert C, Schecker N, Menke S, Glage S, Zweigerdt R, Haverich A (2011) Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 32:2634
Izarra A, Moscoso I, Levent E, Cañón S, Cerrada I, Díez-Juan A, Blanca V, Núñez-Gil I-J, Valiente I, Ruíz-Sauri A (2014) miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Reports 3(6):1029–1042
Jayawardena TM, Finch EA, Zhang L, Zhang H, Hodgkinson C, Pratt RE, Rosenberg PB, Mirotsou M, Dzau VJ (2014) MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res 116:418
Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ (2012) MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 110(11):1465–1473
Judson RL, Babiarz J, Venere M, Blelloch R (2009) Embryonic stem cell specific microRNAs promote induced pluripotency. Nat Biotechnol 27(5):459
Mathew OP, Ranganna K, Yatsu FM (2010) Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother 64(10):733–740. https://doi.org/10.1016/j.biopha.2010.09.017
Choe N, Kwon J-S, Kim J-R, Eom GH, Kim Y, Nam K-I, Ahn Y, Kee HJ, Kook H (2013) The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229(2):348–355
Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J (2009) The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16(12):1590–1598
Cheng Y, Liu X, Yang J, Lin Y, Xu D-Z, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105(2):158–166
Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104(4):476–487. https://doi.org/10.1161/circresaha.108.185363
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100(11):1579–1588. https://doi.org/10.1161/circresaha.106.141986
McDonald RA, White KM, Wu J, Cooley BC, Robertson KE, Halliday CA, McClure JD, Francis S, Lu R, Kennedy S, George SJ, Wan S, van Rooij E, Baker AH (2013) miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. Eur Heart J 34(22):1636–1643. https://doi.org/10.1093/eurheartj/eht105
Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A (2011) MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo novelty and significance. Circ Res 109(8):880–893
Huang K, Bao H, Yan Z-Q, Wang L, Zhang P, Yao Q-P, Shi Q, Chen X-H, Wang K-X, Shen B-R (2017) MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein. Cardiovasc Res 113(5):488–497. https://doi.org/10.1093/cvr/cvw257
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM (2011) MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226(4):1035–1043. https://doi.org/10.1002/jcp.22422
Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478(7369):404–407. https://doi.org/10.1038/nature10486
Zhang J, Zhao F, Yu X, Lu X, Zheng G (2015) MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase. Int J Mol Med 35(6):1708–1714. https://doi.org/10.3892/ijmm.2015.2181
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rotini, A., Giacomazzi, G., Di Filippo, E.S., Sampaolesi, M. (2019). MicroRNAs (miRs) in Muscle Gene Therapy. In: Duan, D., Mendell, J. (eds) Muscle Gene Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-03095-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-03095-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03094-0
Online ISBN: 978-3-030-03095-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)